New drug tested for rare, aggressive adrenal tumors
NCT ID NCT03839498
Summary
This study is testing whether the drug axitinib can shrink or slow the growth of rare adrenal gland tumors called pheochromocytoma and paraganglioma that have spread or returned after treatment. It involves 6 adult participants with confirmed, measurable disease. The main goal is to see how many patients respond to the daily oral medication and how long the disease stays controlled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center
New York, New York, 10031, United States
Conditions
Explore the condition pages connected to this study.